GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $48,000 | +2.1% | 1,245 | +6.0% | 0.02% | -5.6% |
| Q2 2021 | $47,000 | +6.8% | 1,175 | -1.3% | 0.02% | -14.3% |
| Q1 2021 | $44,000 | 0.0% | 1,190 | 0.0% | 0.02% | -4.5% |
| Q4 2020 | $44,000 | -37.1% | 1,190 | -35.9% | 0.02% | -46.3% |
| Q3 2020 | $70,000 | -23.1% | 1,857 | +74.4% | 0.04% | -35.9% |
| Q2 2020 | $91,000 | +2.2% | 1,065 | -54.5% | 0.06% | -17.9% |
| Q1 2020 | $89,000 | -26.4% | 2,341 | -9.1% | 0.08% | -17.9% |
| Q4 2019 | $121,000 | +11.0% | 2,574 | +0.9% | 0.10% | -7.8% |
| Q3 2019 | $109,000 | +11.2% | 2,550 | +4.1% | 0.10% | +19.8% |
| Q2 2019 | $98,000 | -3.0% | 2,450 | +1.3% | 0.09% | +13.2% |
| Q1 2019 | $101,000 | +16.1% | 2,418 | +5.4% | 0.08% | +16.9% |
| Q4 2018 | $87,000 | – | 2,295 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |